CLINICAL_TRIALS
trial_result
· 2021-03-19
Clinical Trial Update: Effect of Progesterone on Latent Phase Prolongation in Patients With Preterm Premature Rupture of Membranes [Phase 2]
Summary
Phase 2 trial evaluating the effect of progesterone on latent phase prolongation in preterm premature rupture of membranes has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ain Shams University | Conditions: Preterm Premature Rupture of Membrane | Phase 2 | Status: COMPLETED